VANCOUVER, June 18, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) a specialty medical device company today announced that CFO Chris Clark is scheduled to present at the JMP Securities Life Sciences Conference in New York City on Wednesday, June 24, 2015, at 1 pm ET.
A live audio webcast of the presentation will be available on the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products in development include Tiara™, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer™ for the treatment of refractory angina. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
For further information: Investor Relations, Neovasc Inc., Chris Clark, 604 248-4138, firstname.lastname@example.org